293 related articles for article (PubMed ID: 4028012)
41. Blood levels of alkylating metabolites of cyclophosphamide in the mouse after iv or oral administration.
Struck RF; Alberts DS
Cancer Treat Rep; 1984 May; 68(5):765-70. PubMed ID: 6722832
[TBL] [Abstract][Full Text] [Related]
42. DNA cross-linking and single-strand breaks induced by teratogenic concentrations of 4-hydroperoxycyclophosphamide and phosphoramide mustard in postimplantation rat embryos.
Little SA; Mirkes PE
Cancer Res; 1987 Oct; 47(20):5421-6. PubMed ID: 3477317
[TBL] [Abstract][Full Text] [Related]
43. Kinetics of phosphoramide mustard hydrolysis in aqueous solution.
Watson E; Dea P; Chan KK
J Pharm Sci; 1985 Dec; 74(12):1283-92. PubMed ID: 4087195
[TBL] [Abstract][Full Text] [Related]
44. Rat and human explant metabolism, binding studies, and DNA adduct analysis of benzo(a)pyrene and its 6-nitro derivative.
Garner RC; Stanton CA; Martin CN; Harris CC; Grafstrom RC
Cancer Res; 1985 Dec; 45(12 Pt 1):6225-31. PubMed ID: 4063973
[TBL] [Abstract][Full Text] [Related]
45. Quantitative high-performance liquid chromatography-electrospray ionization tandem mass spectrometry analysis of bis-N7-guanine DNA-DNA cross-links in white blood cells of cancer patients receiving cyclophosphamide therapy.
Malayappan B; Johnson L; Nie B; Panchal D; Matter B; Jacobson P; Tretyakova N
Anal Chem; 2010 May; 82(9):3650-8. PubMed ID: 20361772
[TBL] [Abstract][Full Text] [Related]
46. Reactions of nitrogen mustards with DNA.
Hemminki K; Kallama S
IARC Sci Publ; 1986; (78):55-70. PubMed ID: 3583398
[TBL] [Abstract][Full Text] [Related]
47. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
48. Persistence of benzo(a)pyrene metabolite:DNA adducts in lung and liver of mice.
Kulkarni MS; Anderson MW
Cancer Res; 1984 Jan; 44(1):97-101. PubMed ID: 6317174
[TBL] [Abstract][Full Text] [Related]
49. Hepatic and pulmonary microsomal metabolism of naphthalene to glutathione adducts: factors affecting the relative rates of conjugate formation.
Buckpitt AR; Bahnson LS; Franklin RB
J Pharmacol Exp Ther; 1984 Nov; 231(2):291-300. PubMed ID: 6491983
[TBL] [Abstract][Full Text] [Related]
50. N-(2,2-Dimethyl-2-(2-nitrophenyl)acetyl)-4-aminocyclophosphamide as a potential bioreductively activated prodrug of phosphoramide mustard.
Jiang Y; Hu L
Bioorg Med Chem Lett; 2008 Jul; 18(14):4059-63. PubMed ID: 18556201
[TBL] [Abstract][Full Text] [Related]
51. Direct detection of the intracellular formation of carboxyphosphamides using nuclear magnetic resonance spectroscopy.
Boal JH; Ludeman SM; Ho CK; Engel J; Niemeyer U
Arzneimittelforschung; 1994 Jan; 44(1):84-93. PubMed ID: 8135883
[TBL] [Abstract][Full Text] [Related]
52. 1,2-benzisoxazole phosphorodiamidates as novel anticancer prodrugs requiring bioreductive activation.
Jain M; Kwon CH
J Med Chem; 2003 Dec; 46(25):5428-36. PubMed ID: 14640551
[TBL] [Abstract][Full Text] [Related]
53. Inhibition in vivo of the formation of adducts between metabolites of benzo(a)pyrene and DNA by butylated hydroxyanisole.
Anderson MW; Boroujerdi M; Wilson AG
Cancer Res; 1981 Nov; 41(11 Pt 1):4309-15. PubMed ID: 6272975
[TBL] [Abstract][Full Text] [Related]
54. 1,3-butadiene: cancer, mutations, and adducts. Part IV: Molecular dosimetry of 1,3-butadiene.
Blair IA; Oe T; Kambouris S; Chaudhary AK
Res Rep Health Eff Inst; 2000 Mar; (92):151-90; discussion 211-9. PubMed ID: 10925841
[TBL] [Abstract][Full Text] [Related]
55. Differential induction of N(2),3-ethenoguanine in rat brain and liver after exposure to vinyl chloride.
Morinello EJ; Koc H; Ranasinghe A; Swenberg JA
Cancer Res; 2002 Sep; 62(18):5183-8. PubMed ID: 12234982
[TBL] [Abstract][Full Text] [Related]
56. [Radiochromatography studies on the metabolism of 3H-cyclophosphamide in sheep].
Schaumlöffel E; Clausnitzer M; Kreyling H
Arzneimittelforschung; 1975 Sep; 25(9):1385-92. PubMed ID: 1242659
[TBL] [Abstract][Full Text] [Related]
57. Pharmacokinetics of N-2-chloroethylaziridine, a volatile cytotoxic metabolite of cyclophosphamide, in the rat.
Lu H; Chan KK
Cancer Chemother Pharmacol; 2006 Oct; 58(4):532-9. PubMed ID: 16470409
[TBL] [Abstract][Full Text] [Related]
58. Susceptibility to aflatoxin B1-induced carcinogenesis correlates with tissue-specific differences in DNA repair activity in mouse and in rat.
Bedard LL; Alessi M; Davey S; Massey TE
Cancer Res; 2005 Feb; 65(4):1265-70. PubMed ID: 15735011
[TBL] [Abstract][Full Text] [Related]
59. Metabolism of 2-amino-alpha-carboline. A food-borne heterocyclic amine mutagen and carcinogen by human and rodent liver microsomes and by human cytochrome P4501A2.
Raza H; King RS; Squires RB; Guengerich FP; Miller DW; Freeman JP; Lang NP; Kadlubar FF
Drug Metab Dispos; 1996 Apr; 24(4):395-400. PubMed ID: 8801053
[TBL] [Abstract][Full Text] [Related]
60. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
